Arkolith/Insider Trading/CERU/Form 4

Walt David R

DirectorCerulean Pharma Inc. (CERU) · full profile →Form 4 · filed Feb 12, 2016
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2016Buy(P)4K$2.03$9K147K
Feb 10, 2016Buy(P)5K$2.08$9K143K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-16-098014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Cerulean Pharma Inc.

Build

Ask your agent about CERU insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-16-098014"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cerulean Pharma Inc.
over the last 90 days and cite the filings.